
Shares of vaccine companies, including Novavax, Inc. (NASDAQ:NVAX), are trading higher amid COVID-19 concerns due to rising cases in China.
Rising COVID-19 cases in China's capital Beijing and Shanghai, where enforcement of a strict "zero-COVID" policy is ongoing, have drawn global attention.